Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0740
-0.0020 (-2.63%)
May 12, 2026, 3:44 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 56.72 million as of May 12, 2026. Its market cap has decreased by -7.83% in one year.
Market Cap
56.72M
Enterprise Value
50.39M
Revenue
5.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 56.72M, an increase of 1,255.82%. That is a compound annual growth rate of 11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 55.22M | 21.26% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 91.87M |
| Immutep | 88.42M |
| Cynata Therapeutics | 79.55M |
| LTR Pharma | 79.07M |
| Botanix Pharmaceuticals | 73.45M |
| Radiopharm Theranostics | 67.34M |
| Amplia Therapeutics | 66.70M |
| Entropy Neurodynamics | 59.56M |